BridgeBio Oncology Therapeutics, Inc. BBOT
- BBO-11818 — Non-Small Cell Lung Cancer Phase 1
- BBO-11818 — Colorectal Cancer Phase 1
- BBO-11818 — Pancreatic Ductal Adenocarcinoma Phase 1
KRAS G12C (3 companies · 8 programs)
Companies with an active program directed at KRAS G12C.
Kura Oncology, Inc. KURA
- darlifarnib — Non-Small Cell Lung Cancer Phase 1
- darlifarnib — Colorectal Cancer Phase 1
- darlifarnib — Pancreatic Ductal Adenocarcinoma Phase 1
Revolution Medicines, Inc. RVMD
- elironrasib — Non-Small Cell Lung Cancer Phase 3
- elironrasib — Colorectal Cancer Phase 1